Amylin, amide, human, a 37-amino acid polypeptide, is a pancreatic hormone cosecreted with insulin that exerts unique roles in metabolism and glucose homeostasis. Amylin, amide, human inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent.
CAT No: HB00087
CAS No:122384-88-7
Synonyms/Alias:Amylin, human amidated;122384-88-7;Diabetes Associated Peptide Amide human;Pancreatic amylin;Amlintide (USAN/INN);PAM-4219-V;D02913;Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly- Ser-Asn-Thr-Tyr-NH2IAPP: Islet Amyloid Polypeptide DAP: Diabetes-Associated Peptide;
Amylin, human amidated, is a synthetic peptide that mirrors the structure and bioactivity of the endogenous human hormone amylin, with an amidated C-terminus enhancing its stability and mimicking the native peptide's physiological form. As a 37-amino acid peptide co-secreted with insulin by pancreatic β-cells, it plays a pivotal role in glucose homeostasis and energy regulation. The amidation at its terminal end not only increases its resistance to enzymatic degradation but also optimizes its interaction with amylin receptors, making it a valuable tool for diverse biochemical and pharmacological investigations. Researchers are drawn to this compound for its well-characterized sequence, high bioactivity, and suitability for in vitro and in vivo studies seeking to elucidate the multifaceted functions of amylin in metabolic pathways. Its ability to form amyloid fibrils under certain conditions also makes it a subject of interest in the study of protein aggregation and its pathological consequences, especially in metabolic and neurodegenerative diseases.
Metabolic Research: Amylin, human amidated, is extensively utilized in metabolic research to dissect the intricate mechanisms governing glucose regulation and energy balance. Scientists employ it in cell-based assays and animal models to investigate how amylin modulates postprandial glucose levels, delays gastric emptying, and suppresses glucagon secretion. These studies provide critical insights into the hormone's physiological roles and its interplay with insulin, contributing to the broader understanding of metabolic homeostasis and the pathophysiology of metabolic disorders.
Amyloid Fibril Formation Studies: In the context of protein aggregation, amidated human amylin serves as a gold standard for modeling amyloid fibril formation in vitro. Its propensity to aggregate under specific conditions enables researchers to study the kinetics and molecular mechanisms of amyloidogenesis. This application is particularly relevant for exploring the factors that drive islet amyloid formation in the pancreas, offering a molecular basis for understanding amyloid-related cytotoxicity and β-cell dysfunction in metabolic diseases.
Receptor Binding and Signal Transduction: The peptide's high affinity for amylin receptors makes it indispensable for receptor binding assays and signal transduction studies. Researchers utilize it to characterize the binding kinetics, receptor specificity, and downstream signaling pathways activated by amylin. By deploying labeled or modified versions of amidated amylin, scientists can map receptor distribution, elucidate receptor-ligand interactions, and identify new therapeutic targets within the amylin signaling axis.
Structure-Activity Relationship (SAR) Analysis: Amidated human amylin is frequently used as a reference compound in structure-activity relationship investigations. By comparing the biological activity of native and modified amylin analogs, researchers can pinpoint critical residues and structural motifs responsible for receptor activation, aggregation propensity, and bioactivity. These SAR studies inform the rational design of novel peptide analogs with tailored pharmacological profiles for experimental and therapeutic development.
Drug Screening and Development: Human amylin, with its well-characterized bioactivity and aggregation properties, is a valuable tool in high-throughput drug screening platforms. It enables the identification and validation of small molecules, peptides, or antibodies that modulate amylin's function or inhibit its aggregation. Such screening efforts are instrumental in the early-stage discovery of compounds that could modulate amylin activity or prevent pathological amyloid formation, accelerating the development of new therapeutic strategies for metabolic and protein aggregation disorders.
Biophysical Characterization: Researchers also leverage amidated amylin for advanced biophysical analyses aimed at unraveling its conformational dynamics, aggregation pathways, and interactions with cellular membranes. Techniques such as circular dichroism, NMR spectroscopy, and electron microscopy are employed to visualize structural transitions and oligomerization states, providing a molecular-level understanding of its behavior in physiological and pathological contexts. These comprehensive applications underscore the versatility and scientific value of Amylin, human amidated, in advancing metabolic, structural, and pharmacological research.
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.